Pyrrolomycins as potential anti-staphylococcal biofilms agents

Biofouling

Volumn 26, Issue 4, 2010, Pages 433-438

  Schillaci, Domenico ^a   Petruso, Salvatore ^a   Raimondi, Maria Valeria ^a   Cusimano, Maria Grazia ^a   Cascioferro, Stella ^a   Scalisi, Marianna ^a   La Giglia, Maria Anna ^b   Vitale, Maria ^b  

^a UNIVERSITY OF PALERMO   (Italy)

^b ISTITUTO ZOOPROFILATTICO SPERIMENTALE DELLA SICILIA A MIRRI   (Italy)

Author keywords

Anti biofilm agents; Pyrrolomycins; Staphylococcal biofilms

Indexed keywords

EID: 77953462779     PISSN: 08927014     EISSN: 10292454     Source Type: Journal    
DOI: 10.1080/08927011003718673     Document Type: Article

References (19)

1. Brady RA, Leid JG, Calhoun JH, Costerton JW, Shirtliff ME. 2008. Osteomyelitis and the role of biofilm in chronic infection. FEMS Immunol Med Microbiol 52: 13-22.
2. Cucarella C, Tormo MA, Ubeda C, Trotonda MP, Monzon M, Peris C, Amorena B, Lasa I, Penades JR. 2004. Role of biofilm-associated protein Bap in the pathogenesis of bovine Staphylococcus aureus. Infec Immun 72: 2177-2185.
3. Donelli G, Francolini I, Romoli D, Guaglianone E, Piozzi A, Ragunath C, Kaplan JB. 2007. Synergistic activity of dispersin B and cefamandole nafate in inhibition of staphylococcal biofilm growth on polyurethanes. Antimicrob Agents Chemother 51: 2733-2740.
4. Ezaki N, Koyama M, Shomura T, Tsuruoka T, Inouye S. 1983. Pyrrolomicins C, D and E, new members of pyrrolomycins. J Antibiot 36: 1263-1267.
5. Gilbert P, Allison DG, McBain AJ. 2002. Biofilms in vitro and in vivo: do singular mechanisms imply crossresistance? J Appl Microbiol 92: 98S-110S.
6. Götz F. 2002. Staphylococcus and biofilms. Mol Microbiol 43: 1367-1378.
7. Gribble GW. 2003. The diversity of naturally produced organohalogenes. Chemosphere 52: 289-297.
8. Mehrotra M, Wang G, Johnson WM. 2000. Multiplex PCR for detection of genes for Staphylococcus aureus enterotoxins, exfoliative toxins, toxic shock syndrome toxin 1, and methicillin resistance. J Clin Microbiol 38: 1032-1035.
9. Melchior MB, Vaarkamp H, Fink-Gremmels J. 2006. Biofilms: a role in recurrent mastitis infections? Vet J 171: 398-407.
10. Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63.
11. O'Gara JP. 2007. ica and beyond: biofilm mechanisms and regulation in Staphylococcus epidermidis and Staphylococcus aureus. FEMS Microbiol Lett 270: 179-188.
12. Otto M. 2008. Staphylococcal biofilms. In: Romeo T, editor. Bacterial biofilms. Curr Top Microbiol Immunol 322: 207-228.
13. Raimondi MV, Cascioferro S, Schillaci D, Petruso S. 2006. Synthesis and antimicrobial activity of new-bromine-rich pyrrole derivatives related to monodeoxypyoluteorin. Eur J Med Chem 41: 1439-1445.
14. Schillaci D, Petruso S, Sciortino V. 2005. 3, 4, 5, 30, 50-Pentabromo-2-(20-hydroxybenzoyl) pyrrole: a potential lead compound as anti-Gram-positive and anti-biofilm agent. Int J Antimicrob Agents 25: 338-340.
15. Suto MJ, Domagala JM, Roland JE, Mailloux GB, Cohen MA. 1992. Fluoroquinolones: relationships between structural variation, mammalian cell cytotoxicity, and antimicrobial activity. J Med Chem 35: 4745-4750.
16. Trampuz A, Zimmerli W. 2006. Antimicrobial agents in orthopaedic surgery: prophylaxis and treatment. Drugs 66: 1089-1105.
17. van Pee KH, Ligon JM. 2000. Biosynthesis of pyrrolnitrin and other phenylpyrrole derivatives by bacteria. Nat Prod Rep 17: 157-164.
18. Walencka E, Rozalska S, Wysokinska H, Rozalski M, Kuzma L, Rozalska B. 2007. Salvipisone and aethiopinone from Salvia sclarea hairy roots modulate staphylococcal antibiotic resistance and express anti-biofilm activity. Planta Med 73: 545-551.
19. Zhang X, Parry RJ. 2006. Cloning and characterization of the pyrrolomycin biosynthetic gene clusters from Actinosporangium vitaminophilum ATCC 31673 and Streptomyces sp. UC 11065. Antimicrob Agents Chemother 51: 946-957.